Literature DB >> 17050741

Community-based seroepidemiological survey of hepatitis E virus infection in Catalonia, Spain.

Maria Buti1, Angela Domínguez, Pere Plans, Rossend Jardí, Mélani Schaper, Jordi Espuñes, Neus Cardeñosa, Francisco Rodríguez-Frías, Rafael Esteban, Antoni Plasència, Luis Salleras.   

Abstract

The objective of the study was to investigate the prevalence of immunoglobulin G (IgG) antibodies to hepatitis E virus (HEV) infection in a population sample from Catalonia and to analyze the demographic and clinical variables associated with the presence of these antibodies. A total of 1,280 subjects between 15 and 74 years of age were selected randomly from urban and rural areas. Data for sociodemographic and clinical variables were collected by using a questionnaire. IgG antibodies to HEV were determined by an immunoenzymatic method. The odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated for studied variables. Multiple logistic regression analysis was used to determine which variables were independently associated with the prevalence of HEV infection. Anti-HEV antibodies were detected in 96 (7.3%) of the 1,280 samples analyzed. The prevalence of antibodies was greater among males (7.8%) than among women (7%) and increased with age for both sexes, from 3% among subjects 15 to 24 years of age to 12% among subjects >/=65 years of age. Bivariate analysis of the sociodemographic and clinical variables showed an association between the prevalence of hepatitis E virus infection and minor surgery (OR, 1.96; 95% CI, 1.24 to 3.11), abdominal surgery (OR, 1.74; 95% CI, 1.12 to 2.73), and, for women, being uniparous or multiparous (OR, 2.84; 95% CI, 1.19 to 6.79). The multivariate analysis showed an association with minor surgery only (OR, 1.68; 95% CI, 1.03 to 2.70). In conclusion, anti-HEV antibodies were detected in 7.3% of the Catalan population. The seroprevalence of anti-HEV antibodies increased with age and was associated with previous minor surgery.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17050741      PMCID: PMC1694449          DOI: 10.1128/CVI.00255-06

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  27 in total

1.  Changing epidemiology of hepatitis A and hepatitis E in urban and rural India (1982-98).

Authors:  V A Arankalle; M S Chadha; S D Chitambar; A M Walimbe; L P Chobe; S S Gandhe
Journal:  J Viral Hepat       Date:  2001-07       Impact factor: 3.728

2.  Epidemiology of hepatitis A and hepatitis E infection and their determinants in adult Chinese community in Hong Kong.

Authors:  K H Wong; Y M Liu; P S P Ng; B W Y Young; S S Lee
Journal:  J Med Virol       Date:  2004-04       Impact factor: 2.327

3.  Rapid and simple method for purification of nucleic acids.

Authors:  R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

4.  Solid-phase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides.

Authors:  G J Dawson; K H Chau; C M Cabal; P O Yarbough; G R Reyes; I K Mushahwar
Journal:  J Virol Methods       Date:  1992-07       Impact factor: 2.014

5.  IgM and IgG antibodies to hepatitis E virus (HEV) detected by an enzyme immunoassay based on an HEV-specific artificial recombinant mosaic protein.

Authors:  M O Favorov; Y E Khudyakov; E E Mast; T L Yashina; C N Shapiro; N S Khudyakova; D L Jue; G G Onischenko; H S Margolis; H A Fields
Journal:  J Med Virol       Date:  1996-09       Impact factor: 2.327

Review 6.  Hepatitis E.

Authors:  K Krawczynski
Journal:  Hepatology       Date:  1993-05       Impact factor: 17.425

7.  Acute hepatitis E by a new isolate acquired in the United States.

Authors:  P Y Kwo; G G Schlauder; H A Carpenter; P J Murphy; J E Rosenblatt; G J Dawson; E E Mast; K Krawczynski; V Balan
Journal:  Mayo Clin Proc       Date:  1997-12       Impact factor: 7.616

8.  Prevalence of antibodies to hepatitis E virus among hemodialysis patients in Sweden.

Authors:  S P Sylvan; S H Jacobson; B Christenson
Journal:  J Med Virol       Date:  1998-01       Impact factor: 2.327

9.  Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992.

Authors:  V A Arankalle; S A Tsarev; M S Chadha; D W Alling; S U Emerson; K Banerjee; R H Purcell
Journal:  J Infect Dis       Date:  1995-02       Impact factor: 5.226

10.  Determination of hepatitis E virus seroprevalence by using recombinant fusion proteins and synthetic peptides.

Authors:  D A Paul; M F Knigge; A Ritter; R Gutierrez; T Pilot-Matias; K H Chau; G J Dawson
Journal:  J Infect Dis       Date:  1994-04       Impact factor: 5.226

View more
  23 in total

1.  Prevalence of hepatitis E virus infection in children in the northeast of Spain.

Authors:  Maria Buti; Pere Plans; Angela Domínguez; Rossend Jardi; Francisco Rodriguez Frias; Rafael Esteban; Luis Salleras; Antoni Plasencia
Journal:  Clin Vaccine Immunol       Date:  2008-03-05

2.  Novel approach for detection of hepatitis E virus infection in German blood donors.

Authors:  Tanja Vollmer; Juergen Diekmann; Reimar Johne; Matthias Eberhardt; Cornelius Knabbe; Jens Dreier
Journal:  J Clin Microbiol       Date:  2012-06-06       Impact factor: 5.948

3.  A nationwide retrospective study on prevalence of hepatitis E virus infection in Italian blood donors.

Authors:  Enea Spada; Simonetta Pupella; Giulio Pisani; Roberto Bruni; Paola Chionne; Elisabetta Madonna; Umbertina Villano; Matteo Simeoni; Sara Fabi; Giuseppe Marano; Cinzia Marcantonio; Patrizio Pezzotti; Anna R Ciccaglione; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2018-05-04       Impact factor: 3.443

4.  Autochthonous hepatitis E in Southwest England: a comparison with hepatitis A.

Authors:  H R Dalton; W Stableforth; S Hazeldine; P Thurairajah; R Ramnarace; U Warshow; S Ijaz; V Ellis; R Bendall
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-02-26       Impact factor: 3.267

5.  Serological immunoassay for detection of hepatitis E virus on the basis of genotype 3 open reading frame 2 recombinant proteins produced in Trichoplusia ni larvae.

Authors:  Nereida Jiménez de Oya; Inmaculada Galindo; Olivia Gironés; Erwin Duizer; José M Escribano; Juan-Carlos Saiz
Journal:  J Clin Microbiol       Date:  2009-08-05       Impact factor: 5.948

6.  Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Mark H Kuniholm; Robert H Purcell; Geraldine M McQuillan; Ronald E Engle; Annemarie Wasley; Kenrad E Nelson
Journal:  J Infect Dis       Date:  2009-07-01       Impact factor: 5.226

7.  Hepatitis E: a complex and global disease.

Authors:  E Pelosi; I Clarke
Journal:  Emerg Health Threats J       Date:  2008-11-07

8.  Widespread distribution of hepatitis E virus in Spanish pig herds.

Authors:  Nereida Jiménez de Oya; Ignacio de Blas; Ana-Belén Blázquez; Miguel A Martín-Acebes; Nabil Halaihel; Olivia Gironés; Juan-Carlos Saiz; Estela Escribano-Romero
Journal:  BMC Res Notes       Date:  2011-10-14

9.  Serological investigation for hepatitis E virus infection in the patients with chronic maintenance hemodialysis from southwest of Iran.

Authors:  Omid R Zekavat; Alireza Makarem; Mohammad Y Karami; Aida Amanat; Maesoomeh Mohandes; Mojtaba Habibagahi
Journal:  Asian J Transfus Sci       Date:  2013-01

10.  Non-travel related Hepatitis E virus genotype 3 infections in the Netherlands; a case series 2004 - 2006.

Authors:  Katrine Borgen; Tineke Herremans; Erwin Duizer; Harry Vennema; Saskia Rutjes; Arnold Bosman; Ana Maria de Roda Husman; Marion Koopmans
Journal:  BMC Infect Dis       Date:  2008-05-08       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.